Clinical Research Directory

The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry

Sponsor: Newcastle University

Summary

Facioscapulohumeral Dystrophy (FSHD) is the third most common form of neuromuscular dystrophy worldwide with an estimated prevalence of one in 20,000. FSHD is an autosomal dominant genetic disease and is estimated to affect up to 3,000 people in the UK. The patient registry facilitates a questionnaire based research study to better characterise and understand the disease in the UK, and helps to identify potential participants eligible for clinical trials.

Official title: The UK Facioscapulohumeral Muscular Dystrophy Patient Registry

Key Details

Conditions

Interventions

Locations (1)